The COVID-19 vaccine concerns scale: Development and validation of a new measure

9Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Reasons for COVID-19 hesitancy are multi-faceted and tend to differ from those for general vaccine hesitancy. We developed the COVID-19 Vaccine Concerns Scale (CVCS), a self-report measure intended to better understand individuals’ concerns about COVID-19 vaccines. We validated the scale using data from a convenience sample of 2,281 emergency medical services providers, a group of professionals with high occupational COVID-19 risk. Measures included the CVCS items, an adapted Oxford COVID-19 vaccine hesitancy scale, a general vaccine hesitancy scale, demographics, and self-reported COVID-19 vaccination status. The CVCS had high internal consistency reliability (α =.89). A one-factor structure was determined by exploratory and confirmatory factor analyses (EFA and CFA), resulting in a seven-item scale. The model had good fit (X2[14] = 189.26, p

Cite

CITATION STYLE

APA

Gregory, M. E., MacEwan, S. R., Powell, J. R., Volney, J., Kurth, J. D., Kenah, E., … McAlearney, A. S. (2022). The COVID-19 vaccine concerns scale: Development and validation of a new measure. Human Vaccines and Immunotherapeutics, 18(5). https://doi.org/10.1080/21645515.2022.2050105

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free